Why is Mankind Pharma falling/rising?

As of 14-Jul, Mankind Pharma Ltd's stock price is rising, currently at 2,699.80, reflecting an increase of 129.8 or 5.05%. The stock has shown strong performance today, outperforming its sector by 4.15% and achieving a consecutive gain over the last five days, with a total return of 11.47% in that period. Additionally, the stock has reached an intraday high of Rs 2706.25, and it is trading above all key moving averages, indicating positive momentum. The rising investor participation, evidenced by a significant increase in delivery volume, further supports the stock's upward trajectory. The company also boasts a high management efficiency with a return on equity of 19.25%, a low debt-to-equity ratio, and healthy long-term growth in operating profit, which has grown at an annual rate of 23.44%. Furthermore, high institutional holdings at 24.4% suggest that informed investors are backing the stock, contributing to its recent gains.
In the broader market context, Mankind Pharma's short-term return of 11.47% over the past week significantly outpaces the Sensex, which has declined by 1.42% during the same period. This stark contrast highlights the stock's resilience and attractiveness relative to the overall market. While the stock has underperformed year-to-date with a decline of 6.15% compared to the Sensex's gain of 5.27%, its strong one-year return of 25.43% far exceeds the market's modest return of 2.15%. This performance indicates that despite some volatility, Mankind Pharma is currently positioned favorably against broader market trends, contributing to its rising stock price.